A Dual Energy CT-Guided Intelligent Radiation Therapy Platform.

Ning Wen, Yibin Zhang, Haoran Zhang, Maochen Zhang, Jingjie Zhou, Yanfang Liu, Can Liao, Lecheng Jia, Kang Zhang, Jiayi Chen
{"title":"A Dual Energy CT-Guided Intelligent Radiation Therapy Platform.","authors":"Ning Wen, Yibin Zhang, Haoran Zhang, Maochen Zhang, Jingjie Zhou, Yanfang Liu, Can Liao, Lecheng Jia, Kang Zhang, Jiayi Chen","doi":"10.1016/j.ijrobp.2025.01.028","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>The integration of advanced imaging and artificial intelligence (AI) technologies in radiotherapy has revolutionized cancer treatment by enhancing precision and adaptability. This study introduces a novel Dual Energy CT (DECT)-Guided Intelligent Radiation Therapy (DEIT) platform designed to streamline and optimize the radiotherapy process. The DEIT system combines DECT, a newly designed dual-layer multi-leaf collimator, deep learning algorithms for auto-segmentation, automated planning and QA capabilities.</p><p><strong>Methods: </strong>The DEIT system integrates an 80-slice CT scanner with an 87 cm bore size, a linear accelerator delivering four photon and five electron energies, and a flat panel imager optimized for MV Cone Beam CT acquisition. A comprehensive evaluation of the system's accuracy was conducted using end-to-end tests. Virtual monoenergetic CT images and electron density images of the DECT were generated and compared on both phantom and patient. The system's auto-segmentation algorithms were tested on five cases for each of the 99 organs at risk, and the automated optimization and planning capabilities were evaluated on clinical cases.</p><p><strong>Results: </strong>The DEIT system demonstrated systematic errors of less than 1 mm for target localization. DECT reconstruction showed electron density mapping deviations ranging from -0.052 to 0.001, with stable HU consistency across monoenergetic levels above 60 keV, except for high-Z materials at lower energies. Auto-segmentation achieved dice similarity coefficients above 0.9 for most organs with inference time less than 2 seconds. Dose-volume histogram (DVH) comparisons showed improved dose conformity indices and reduced doses to critical structures in Auto-plans compared to Manual Plans across various clinical cases. Additionally, high gamma passing rates at 2%/2mm in both 2D (above 97%) and 3D (above 99%) in vivo analyses further validate the accuracy and reliability of treatment plans.</p><p><strong>Conclusions: </strong>The DEIT platform represents a viable solution for radiation treatment. The DEIT system utilizes AI-driven automation, real-time adjustments, and CT imaging to enhance the radiotherapy process, improving both efficiency and flexibility.</p>","PeriodicalId":14215,"journal":{"name":"International Journal of Radiation Oncology Biology Physics","volume":" ","pages":""},"PeriodicalIF":6.4000,"publicationDate":"2025-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Radiation Oncology Biology Physics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.ijrobp.2025.01.028","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: The integration of advanced imaging and artificial intelligence (AI) technologies in radiotherapy has revolutionized cancer treatment by enhancing precision and adaptability. This study introduces a novel Dual Energy CT (DECT)-Guided Intelligent Radiation Therapy (DEIT) platform designed to streamline and optimize the radiotherapy process. The DEIT system combines DECT, a newly designed dual-layer multi-leaf collimator, deep learning algorithms for auto-segmentation, automated planning and QA capabilities.

Methods: The DEIT system integrates an 80-slice CT scanner with an 87 cm bore size, a linear accelerator delivering four photon and five electron energies, and a flat panel imager optimized for MV Cone Beam CT acquisition. A comprehensive evaluation of the system's accuracy was conducted using end-to-end tests. Virtual monoenergetic CT images and electron density images of the DECT were generated and compared on both phantom and patient. The system's auto-segmentation algorithms were tested on five cases for each of the 99 organs at risk, and the automated optimization and planning capabilities were evaluated on clinical cases.

Results: The DEIT system demonstrated systematic errors of less than 1 mm for target localization. DECT reconstruction showed electron density mapping deviations ranging from -0.052 to 0.001, with stable HU consistency across monoenergetic levels above 60 keV, except for high-Z materials at lower energies. Auto-segmentation achieved dice similarity coefficients above 0.9 for most organs with inference time less than 2 seconds. Dose-volume histogram (DVH) comparisons showed improved dose conformity indices and reduced doses to critical structures in Auto-plans compared to Manual Plans across various clinical cases. Additionally, high gamma passing rates at 2%/2mm in both 2D (above 97%) and 3D (above 99%) in vivo analyses further validate the accuracy and reliability of treatment plans.

Conclusions: The DEIT platform represents a viable solution for radiation treatment. The DEIT system utilizes AI-driven automation, real-time adjustments, and CT imaging to enhance the radiotherapy process, improving both efficiency and flexibility.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
11.00
自引率
7.10%
发文量
2538
审稿时长
6.6 weeks
期刊介绍: International Journal of Radiation Oncology • Biology • Physics (IJROBP), known in the field as the Red Journal, publishes original laboratory and clinical investigations related to radiation oncology, radiation biology, medical physics, and both education and health policy as it relates to the field. This journal has a particular interest in original contributions of the following types: prospective clinical trials, outcomes research, and large database interrogation. In addition, it seeks reports of high-impact innovations in single or combined modality treatment, tumor sensitization, normal tissue protection (including both precision avoidance and pharmacologic means), brachytherapy, particle irradiation, and cancer imaging. Technical advances related to dosimetry and conformal radiation treatment planning are of interest, as are basic science studies investigating tumor physiology and the molecular biology underlying cancer and normal tissue radiation response.
期刊最新文献
A Phase 2 Trial of Radium223 and Stereotactic Ablative Radiotherapy in Hormone-Naïve Men with Oligometastatic Prostate Cancer to Bone: The RadSABR study. Concurrent and consolidative carboplatin plus nab-paclitaxel or paclitaxel in locally advanced NSCLC A multicenter, randomized clinical trial. The Benefit of Short-Term Androgen Deprivation Therapy with Radiotherapy for Intermediate-Risk Prostate Cancer. A Dual Energy CT-Guided Intelligent Radiation Therapy Platform. Carbon ion radiotherapy with pencil beam scanning for stage III non-small cell lung cancer: toxicity profiles, survival outcomes, and prognostic indicators.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1